Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » Real-world management and patient perspectives on QOL with neuroendocrine tumours: An ANZ perspective

Real-world management and patient perspectives on QOL with neuroendocrine tumours: An ANZ perspective

  • July 27, 2021

On 2 September 2020 a webinar was held titled “NET 2020” for Health Professionals and was sponsored by Novartis.

There were around 120 attendees at the event from across Australia which had a panel of NET Specialists providing information about current treatment options, an opportunity to take part in an in-depth discussion of a functional GEPNET patient case, a debate on the optimal clinical approach for non-functional GEPNET, and new data on quality of life issues affecting NET patients to improve supportive care. This article provides a summary of the presentations at the event which will be extremely interesting to the medical community.

Click the button below for full article.

Download here

Share this post

Recent posts

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

February 9, 2026

Australia delivers excellent cancer care, but not equally

February 4, 2026

NECA Contributes to Multidisciplinary Systemic Review

January 28, 2026

AUS-NET Update, January 2026

January 20, 2026
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNETs Q&A 2021
NextNew Normal, Same Cancer CampaignNext

Related Posts

Australia delivers excellent cancer care, but not equally

Meredith Cummins is CEO of NeuroEndocrine Cancer Australia and incoming President of the International Neuroendocrine Cancer Alliance, representing patient advocacy groups worldwide. Every World Cancer

NECA Contributes to Multidisciplinary Systemic Review

NECA was invited to participate and co-author in a multidisciplinary working group to conduct a systematic review and meta-analysis to evaluate the current evidence on

AUS-NET Update, January 2026

The AUS-NET trial commenced in 2022 and is running through to 2027. Across the five Centres of Excellence—The Queen Elizabeth Hospital, Royal North Shore Hospital,

CommNETs 2025

The 2025 CommNETs Annual Meeting was held in Vancouver on 5–6 December, bringing together neuroendocrine cancer specialists from across Commonwealth countries. CommNETs (Commonwealth Neuroendocrine Tumour

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2026 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin